Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
14th week of 2020 patent applcation highlights part 7
Patent application number
Title
Published
20200101017
PREPARATION OF DESICCATED LIPOSOMES FOR USE IN COMPRESSIBLE DELIVERY SYSTEMS
2020-04-02
20200101018
COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
2020-04-02
20200101019
USE OF LIPOSOMES FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B
2020-04-02
20200101020
OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM
2020-04-02
20200101022
FORMULATIONS OF CYSTEAMINE AND CYSTAMINE
2020-04-02
20200101023
METHODS OF PREPARING POLYELECTROLYTE COMPLEX NANOPARTICLES
2020-04-02
20200101024
IMPROVED FIBRINOGEN-BASED TISSUE ADHESIVE PATCH
2020-04-02
20200101025
Transdermal Drug Delivery System
2020-04-02
20200101027
TOPICAL PHARMACEUTICAL COMPOSITIONS
2020-04-02
20200101028
EFFECTIVE SENSITIZING DOSE OF A GELLED IMMUNOMODULATING TOPICAL COMPOSITION
2020-04-02
20200101029
METHOD AND SYSTEM FOR PRESERVING COGNITIVE CAPACITY DURING AGING
2020-04-02
20200101030
MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
2020-04-02
20200101031
METHODS FOR TREATING NEUROLOGICAL DISORDERS
2020-04-02
20200101032
METHOD FOR ENHANCING ENERGY PRODUCTION AND METABOLISM IN CELLS
2020-04-02
20200101033
High-Stability Packaged Solutions of T4 Thyroid Hormone
2020-04-02
20200101034
RAPID AND CONTROLLED DELIVERY OF COMPOSITIONS WITH RESTORED ENTOURAGE EFFECTS
2020-04-02
20200101035
COMPOSITIONS AND METHODS COMPRISING C16:1N7-PALMITOLEATE
2020-04-02
20200101036
METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID
2020-04-02
20200101037
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
2020-04-02
20200101038
ALTERTOXIN II AS A SELECTIVE INHIBITOR OF EWING FAMILY OF TUMOR CELLS
2020-04-02
20200101039
Taxane Particles and Their Use
2020-04-02
20200101040
PHARMACEUTICAL COMPOSITIONS COMPRISING A HYDROXYETHYLQUERCETIN GLUCURONIDE METABOLITE
2020-04-02
20200101041
METHODS AND COMPOSITIONS FOR ENHANCING HEALTH
2020-04-02
20200101042
4-METHYLUMBELLIFERONE TREATMENT FOR IMMUNE MODULATION
2020-04-02
20200101043
COMBINATIONS AND METHODS FOR THE TREATMENT OF NEUROPATHIC PAIN
2020-04-02
20200101044
FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
2020-04-02
20200101045
USE OF TRADIPITANT IN MOTION SICKNESS
2020-04-02
20200101046
IL-8 INHIBITORS FOR USE IN THE TREATMENT AND/OR PREVENTION OF BACTERIAL SECONDARY INFECTIONS
2020-04-02
20200101047
INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
2020-04-02
20200101048
ANTIBACTERIAL AGENTS INCLUDING HISTIDINE KINASE INHIBITORS
2020-04-02
20200101049
COMBINATION THERAPY FOR TREATMENT OF RESTENOSIS
2020-04-02
20200101050
THYMOQUINONE/HARMALINE AND RELATED REACTION PRODUCTS
2020-04-02
20200101051
MACROCYCLE AND COMPOSITION COMPRISING THEREOF
2020-04-02
20200101052
THE USE OF N-(4-IODOBENZOYLAMINO)-5-ETHYL-1,2,3,6-TETRAHYDROPYRIDINE AS A TREATMENT FOR CANCER
2020-04-02
20200101053
METHOD OF TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION BY ADMINISTERING MILRINONE
2020-04-02
20200101054
SUSTAINED-RELEASE INJECTION PREPARATION CONTAINING DONEPEZIL AND PREPARATION METHOD THEREFOR
2020-04-02
20200101055
CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN
2020-04-02
20200101056
USE OF ROCK INHIBITORS FOR PROMOTING SINONASAL EPITHELIAL CELL REPAIR
2020-04-02
20200101057
COMBINATION THERAPY AGAINST CHEMORESISTANCE IN LEUKEMIA
2020-04-02
20200101058
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
2020-04-02
20200101059
TREATMENT OF PEMPHIGUS
2020-04-02
20200101060
Method of Treating Multiple Sclerosis
2020-04-02
20200101061
4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT
2020-04-02
20200101062
USE OF MACROAZAPYRIDINOPHANES METAL COMPLEXES IN THE TREATMENT OF DISEASES
2020-04-02
20200101063
TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
2020-04-02
20200101064
COMBINATION FOR USE IN THE TREATMENT OF LUNG CANCER
2020-04-02
20200101066
AGENT THAT INCREASES THE EXPRESSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
2020-04-02
20200101067
USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS
2020-04-02
20200101068
Heteroaryl Derivatives as PARP Inhibitors
2020-04-02
20200101069
CRAC CHANNEL INHIBITORS FOR THE TREATMENT OF STROKE AND TRAUMATIC BRAIN INJURY
2020-04-02
20200101070
METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY
2020-04-02
20200101071
THERAPEUTIC REGIMENS FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
2020-04-02
20200101072
HIV POST-EXPOSURE PROPHYLAXIS
2020-04-02
20200101073
DEPOT FORMULATIONS
2020-04-02
20200101074
A PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METHOTREXATE AND NOVOBIOCIN, AND THE USE OF SAID COMPOSITION IN THERAPY
2020-04-02
20200101075
APPLICATION OF N-BENZYL TRYPTANTHRIN DERIVATIVE AS TRYPTOPHAN DIOXYGENASE (TDO) INHIBITOR
2020-04-02
20200101076
PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF CYTOKINE RELEASE SYNDROME
2020-04-02
20200101077
COMBINATION THERAPY
2020-04-02
20200101078
HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
2020-04-02
20200101079
ANTICANCER COMBINATION THERAPY
2020-04-02
20200101080
INHIBITORS OF DNA PK AND USES THEREOF
2020-04-02
20200101081
COMBINATION THERAPY FOR TREATING CANCER
2020-04-02
20200101082
TOPICAL ANTIMICROBIAL COMPOSITIONS AND METHODS OF FORMULATING THE SAME
2020-04-02
20200101083
CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES
2020-04-02
20200101084
USE OF NOR-BILE ACIDS IN THE TREATMENT OF ARTERIOSCLEROSIS
2020-04-02
20200101085
TRANSPORE DELIVERY OF DRUGS AND USES THEREOF
2020-04-02
20200101086
USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION
2020-04-02
20200101087
PHARMACEUTICAL COMPOSITIONS AND METHODS
2020-04-02
20200101088
COMPOSITIONS AND METHODS FOR SUPPRESSING OR REDUCING SYSTEMIC IMMUNE RESPONSE IN A SUBJECT
2020-04-02
20200101089
ADJUNCTIVE THERAPY WITH 25-HYDROXYVITAMIN D AND ARTICLES THEREFOR
2020-04-02
20200101090
USE OF AMINOSALICYLATES IN DIARRHOEA-PREDOMINENT IRRITABLE BOWEL SYNDROME
2020-04-02
20200101091
ACYLNUCLEOSIDE PHOSPHONATES, PRODRUGS THEREOF AND USE THEREOF AS MEDICAMENT
2020-04-02
20200101092
COMPOSITION FOR PREVENTING OR TREATING CHRONIC RENAL TRANSPLANT DYSFUNCTION COMPRISING BISPHOSPHONATE
2020-04-02
20200101093
Methods of Treating and Preventing Neuropsychiatric and/or Neurocognitive Complications in Patients Infected with HIV
2020-04-02
20200101094
SYNTHETIC COMPOSITION COMPRISING OLIGOSACCHARIDES AND ITS USE IN MEDICAL TREATMENT
2020-04-02
20200101095
ISOTOPOLOGUES OF 5-AZACYTIDINE
2020-04-02
20200101096
Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
2020-04-02
20200101097
Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
2020-04-02
20200101098
METHODS FOR THE TREATMENT AND PROPHYLAXIS OF HIV AND AIDS
2020-04-02
20200101099
Compositions and Methods for Altering Tissue Specificity and Improving AAV9-Mediated Gene Transfer
2020-04-02
20200101100
Transgene-Cytotoxic Combination Therapy
2020-04-02
20200101101
DNA ORIGAMI NANOSTRUCTURES FOR TREATMENT OF ACUTE KIDNEY INJURY
2020-04-02
20200101102
TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS
2020-04-02
20200101103
REINFORCEMENT OF MUCUS BARRIER PROPERTIES
2020-04-02
20200101104
FOOD COMPOSITIONS FOR MANAGING BODY WEIGHT
2020-04-02
20200101105
UTILIZING POLYMERS AND ANTIBIOTICS TO ENHANCE ANTIMICROBIAL ACTIVITY AND INHIBIT ANTIBIOTIC RESISTANCE
2020-04-02
20200101106
IN VIVO PRIMING OF NATURAL KILLER CELLS
2020-04-02
20200101107
ISOLATION OF STABLE REGULATORY T CELLS AND USES THEREOF
2020-04-02
20200101108
METHODS OF TREATING T CELL EXHAUSTION BY INHIBITING OR MODULATING T CELL RECEPTOR SIGNALING
2020-04-02
20200101109
Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy
2020-04-02
20200101110
KINASE MUTANTS AND USES THEREOF
2020-04-02
20200101111
QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES
2020-04-02
20200101112
RENAL CELL POPULATIONS AND USES THEREOF
2020-04-02
20200101113
BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) PRECURSOR CELLS FOR THERAPEUTIC APPLICATIONS
2020-04-02
20200101114
PHARMACEUTICAL COMPOSITION FOR USE IN IMPROVING QUALITY OF SCALP OR SKIN, WOUND HEALING, OR IMPROVING QUALITY OF HAIR
2020-04-02
20200101115
BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF
2020-04-02
20200101116
HUMAN HOMOGENEOUS AMNIOTIC FLUID STEM CELL LINES AND USES THEREOF
2020-04-02
20200101117
METHODS OF CARDIAC REPAIR
2020-04-02
20200101118
METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
2020-04-02
20200101119
METHODS OF TREATMENT OF INFECTIONS USING BACTERIA
2020-04-02